Clinical Trials
4 trialsNCT06634199 2026-01-28
SIENNA
Fundación GECP
Recruiting
NCT04364776 2023-09-28
Radiomic Signature as Predictive Marker of Response to Chemoradiation and Durvalumab in Stage III NSCLC.
Fondazione IRCCS Policlinico San Matteo di Pavia
Unknown
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
NCT04285866 2022-06-07
S-REAL
Fundación GECP
Completed